logo_hcam

Revista Médica Científica CAMbios

Periodicidad semestral: flujo continuo.

ISSN - Electrónico: 2661-6947 / DOI: 10.36015 • LILACS BIREME (19784); LATINDEX (20666)

Ver PDF (Spanish)
Ver HTML (Spanish)
Ver EPUB (Spanish)

Keywords

Venous Thromboembolism/complications
Primary Prevention/methods
Pulmonary Embolism
Venous Thrombosis
Thromboembolism/drug therapy
Vascular Diseases/ prevention & control
Vein
Heparin/therapeutic use

How to Cite

1.
Risk of venous thromboembolism and adequate use of thromboprophylactic therapy. Cambios rev. méd. [Internet]. 2021 Sep. 29 [cited 2025 Dec. 7];20(1):26-32. Available from: https://revistahcam.iess.gob.ec/index.php/cambios/article/view/508

Abstract

INTRODUCTION. Venous thromboembolism is a preventable complication in hospitalized patients and risk stratification improves patient safety, its ocurrence is prevented by its assessment. OBJECTIVE. To evaluate the risk of venous thromboembolism and adequate use of thromboprophylactic therapy in hospitalized patients. MATERIALS AND METHODS. Cross-sectional analytical study. Population of 412 and sample of 373 patients surveyed, distributed: 186 in clinical wards, 163 in surgical wards and 24 in obstetrics of the Carlos Andrade Marín Specialties Hospital, from february 21 to 23, 2019. Data tabulation and analysis was performed in the statistical program International Business Machines Statistical Package for the Social Sciences, version 21. RESULTS. 76,67% (286; 373) of patients were categorized as high risk of venous thromboembolism; 49,46% (144; 163) post-surgical and 69,40% (129; 286) clinical patients as high risk of venous thromboembolism, with 38,80% (56; 144) of surgical and 57,40% (74; 129) of clinical patients receiving
adequate pharmacological thromboprophylaxis. CONCLUSIONS. The use of nonpharmacological and pharmacological thromboprophylaxis with low-molecular-weight heparin in hospitalized patients at risk of venous thromboembolism was low.

Ver PDF (Spanish)
Ver HTML (Spanish)
Ver EPUB (Spanish)

References

Cohen AT, Tapson VF, Bergmann J-F, Goldhaber SZ, Kakkar AK, Deslandes B, et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. The Lancet [Internet]. 2008 Feb 2;371(9610):387–94. DOI: 10.1016/S0140-6736(08)60202-0. Available from: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(08)60202-0/abstract.

Boonyawat K, Crowther M. Venous Thromboembolism Prophylaxis in Critically Ill Pat--ients. Seminars in thrombosis and hemostasis [Internet]. 2015 Jan 16;41(01): 068-074. Available from: https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0034-1398386

Martínez-Zubieta R. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE II study): Mexican results of a national cross-sectional study. Cirugía y Cirujanos [Internet]. 2010;78(4):333–41. Available from: https://www.medigraphic.com/cgi-bin/new/resumenI.cgi?IDARTICULO=25070

Schünemann HJ, Cushman M, Burnett AE, Kahn SR, Beyer-Westendorf J, Spencer FA, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients. Blood Adv [Internet]. 2018. 27;2(22):3198–225. Available from: https://ashpublications.org/bloodadvances/article-lookup/doi/10.1182/bloodadvances.2018022954

Sajid MS, Desai M, Morris RW, Hamilton G. Knee length versus thigh length graduated compression stockings for prevention of deep vein thrombosis in postoperative surgical patients. Cochrane Database Syst Rev [Internet]. 2012 May 16;(5):CD007162. Available from: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007162.pub2/abstract

Luna O, Stephanía A. Comparación de tromboprofilaxis en pacientes clínicos y quirúrgicos hospitalizados en el Hospital de Especialidades Eugenio Espejo en el período septiembre-octubre 2014. Pontificia Universidad Católica del Ecuador [Internet]. 2015. URI: http://repositorio.puce.edu.ec/handle/22000/7686. Disponible en: http://repositorio.puce.edu.ec/handle/22000/7686

González Valdiviezo BL, Palacios Coello LF. Uso de medidas profilácticas acorde a clasificación de riesgo de trombo embolismo venoso y morbilidad de trombosis venosa profunda en los servicios clínicos y quirúrgicos del Hospital Enrique Garcés Quito durante mayo a julio 2015. Pontificia Universidad Católica del Ecuador [Internet]. 2015; URI: http://repositorio.puce.edu.ec/handle/22000/10419. Disponible en: http://repositorio.puce.edu.ec/handle/22000/10419

Roberts LN, Durkin M, Arya R. Annotation: Developing a national programme for VTE prevention. British Journal of Haematology [Internet]. 2017 178(1):162–70. DOI: https://doi.org/10.1111/bjh.14769. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.14769

Amin AN, Lin J, Yang G, Stemkowski S. Are There Any Differences in the Clinical and Economic Outcomes Between US Cancer Patients Receiving Appropriate or Inappropriate Venous Thromboembolism Prophylaxis? J Oncol Pract [Internet]. 2009 Jul;5(4):159-64. Available from: https://ascopubs.org/doi/full/10.1200/JOP.0942002?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed

Palareti G, Poli D. The prevention of venous thromboembolism recurrence in the elderly: a still open issue. Expert Rev Hematol [Internet]. 2018 Nov;11(11):903-909. DOI: https://doi.org/10.1080/17474086.2018.1526667. Available from: https://www.tandfonline.com/doi/full/10.1080/17474086.2018.1526667

Tapson VF, Decousus H, Pini M, Chong BH, Froehlich JB, Monreal M, et al. Venous Thromboembolism Prophylaxis in Acutely Ill Hospitalized Medical Patients: Findings From the International Medical Prevention Registry on Venous Thromboembolism. Chest [Internet]. 2007 Sep 1; 132(3):936–45. DOI: https://doi.org/10.1378/chest.06-2993. Available from: http://www.sciencedirect.com/science/article/pii/S0012369215366617

Kahn S, Panju A, Geerts W, Pineo G, Desjardins L, Turpie A, et al. Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada. Thrombosis research[Internet]. 2007 Dec 31;119:145–55. DOI: https://doi.org/10.1016/j.thromres.2006.01.011. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0049-3848(06)00039-9

Baglin T, Barrowcliffe TW, Cohen A, Greaves M. Guidelines on the use and monitoring of heparin. British Journal of Haematology [Internet]. 2006; 133(1):19–34. Available from:

https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-2141.2005.05953.x

Recommendations | Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism | Guidance | NICE [Internet]. Available from: https://www.nice.org.uk/guidance/ng89/chapter/Recommendations

Akinbobuyi O, Shalders L, Nokes T. Ensuring timely thromboprophylaxis on a Medical Assessment Unit. BMJ Open Quality [Internet]. 2016 Nov 1;5(1). Available from: https://bmjopenquality.bmj.com/content/5/1/u212414.w4934

Nassif Kerbauy M, de Moraes FY, Kerbauy LN, Oliveira Conterno L de, El-Fakhouri S. Venous thromboprophylaxis in medical patients: an application review. Revista da Associação Médica Brasileira (English Edition) [Internet]. 2013 Jan 1;59(3):258–64. Available from: http://www.sciencedirect.com/science/article/pii/S2255482313704661

Garcia DA, Baglin TP, Weitz JI, Samama MM. Parenteral Anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. CHEST [Internet]. 2012 Feb 1;141(2):e24S-e43S. DOI: https://doi.org/10.1378/chest.11-2291 Available from: https://journal.chestnet.org/article/S0012-3692(12)60118-4/abstract

Chan K, Thadhani R, Maddux F. No difference in bleeding risk between subcutaneous enoxaparin and heparin for thromboprophylaxis in end-stage renal disease. Kidney international [Internet]. 2013 May 15;84. DOI: https://doi.org/10.1038/ki.2013.152. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0085-2538(15)55990-5

Pai M, Adhikari NKJ, Ostermann M, Heels-Ansdell D, Douketis JD, Skrobik Y, et al. Low-molecular-weight heparin venous thromboprophylaxis in critically ill patients with renal dysfunction: A subgroup analysis of the PROTECT trial. PLOS ONE [Internet]. 2018 Jun 1;13(6):e0198285. Available from: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0198285

Karaoui LR, Tawil S, Salameh P, Chamoun N. Enoxaparin 20 mg for thromboprophylaxis in severe renal impairment. J Int Med Res [Internet]. 2019 Jan 1; 47(1):225–34. DOI: https://doi.org/10.1177/0300060518799896. Available from: https://journals.sagepub.com/doi/10.1177/0300060518799896

Anderson DR, Morgano GP, Bennett C, Dentali F, Francis CW, Garcia DA, et al. American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients. Blood Adv [Internet]. 2019 Dec 10;3(23):3898–944. Available from: https://ashpublications.org/bloodadvances/article/3/23/3898/429211/American-Society-of-Hematology-2019-guidelines-for

Islam MS, editor. Thrombosis and Embolism: from Research to Clinical Practice: Volume 1 [Internet]. Springer International Publishing; 2017. (Advances in Internal Medicine). Available from: https://www.springer.com/gp/book/9783319221076

 

The authors who publish in this journal accept the following conditions:

1. The authors retain the copyright and grant to the CAMbios MEDICAL-SCIENTIFIC JOURNAL HECAM the right of the first publication, with the work registered with the Creative Commons attribution license, which allows third parties to use the published material provided that they mention the authorship of the work and the first publication in this journal.

2. Authors can make other independent and additional contractual agreements for the non-exclusive distribution of the version of the article published in this journal (for example, include it in an institutional repository or publish it in a book) as long as it clearly indicates that the work was published. for the first time in the CAMbios MEDICAL-SCIENTIFIC JOURNAL HECAM.